ATM and juvenile Huntington disease: Interestingly, the role of ATM inhibition as a potential therapeutic approach to counteracting neurodegeneration has been explored in Huntington’s disease (HD), where ATM genetic deficiency and the pharmacological inhibition achieved by KU-60019 are associated with an amelioration of pathological features [94].